Optimizing Administration of CAR T-Cell Therapy During the COVID-19 Pandemic.

Optimizing Administration of CAR T-Cell Therapy During the COVID-19 Pandemic. Clin Adv Hematol Oncol. 2020 Jul;18(7):400-403 Authors: Bishop MR PMID: 32903251 [PubMed - in process]

https://www.ncbi.nlm.nih.gov/pubmed/32903251?dopt=Abstract

Source: Clinical Advances in Hematology and Oncology - September 11, 2020 Category: Cancer & Oncology Tags: Clin Adv Hematol Oncol Source Type: research

More News: Cancer & Oncology | COVID-19 | Hematology | Pandemics